Cevec Pharmaceuticals GmbH Our company is a global solution provider focusing on the development of top notch human expression systems with highest ethical standards. Our platform expression technologies CAP and CAP-T are based on specific, amniocyte derived human cell lines. CAP and CAP-T are designed for stable and transient protein production and achieve highest protein yields with authentic human glycosylation patterns. We have a high focus on research & development, production and marketing of our cell systems for protein and vaccine production accompanied by our development of selected “bio-better” and “bio-superior” candidates. The company actively started to out-license its technologies worldwide in 2005. Founded by a group of internationally renowned scientists and clinicians from the University of Cologne, the company now supports CROs, CMOs, BioTechs and Pharmaceutical companies all over the world. Our headquarter is in Cologne.